Sheridan Capital Partners, a lower mid-market private equity firm focused on health care, raised $575 million for its third fund.
The fund was oversubscribed, exceeding its target of $450 million.
The fund will continue Sheridan’s strategy of making control investments in North American founder-owned businesses with $3-20 million of EBITDA. Sheridan is led by partners Jonathan Lewis and Sean Dempsey. Read more.
